Sign In
Buy CTIC
$9.09
+0 (+0%)
At Close: Sep 22, 2023
Sobi completes acquisition of CTI BioPharma Corp.
09:45am, Monday, 26'th Jun 2023
STOCKHOLM , June 26, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced today the completion of the acquisition of CTI b
Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
06:49am, Saturday, 24'th Jun 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTIO
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CTI BioPharm
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
04:35pm, Tuesday, 30'th May 2023
SEATTLE , May 30, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies f
Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
07:46am, Thursday, 25'th May 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTIO
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CTI BioPharm
CTI BioPharma skyrockets on acquisition by Sobi
11:13am, Wednesday, 10'th May 2023
CTI BioPharma shares added almost 85% on the news that the company would be acquired by Stockholm-based hematology and immunology leader Swedish Orphan Biovitrum AB (Sobi). Seattle-based CTI is a biop
Why Shares of CTI BioPharma Are Soaring Wednesday
10:51am, Wednesday, 10'th May 2023
CTI BioPharma has one FDA-approved therapy, Vonjo, to treat a rare form of bone marrow cancer. The company is being bought at a 89% premium from its closing price on Tuesday.
Shareholder Alert: Ademi LLP investigates whether CTI BioPharma Corp. has obtained a Fair Price in its transaction with Sobi
09:45am, Wednesday, 10'th May 2023
MILWAUKEE , May 10, 2023 /PRNewswire/ -- Ademi LLP is investigating CTI BioPharma (Nasdaq: CTIC) for possible breaches of fiduciary duty and other violations of law in its transaction with Sobi. Cli
U.S. stock futures climb as inflation continues to cool
09:26am, Wednesday, 10'th May 2023
U.S. stock index futures climbed on Wednesday after data showed U.S. consumer price inflation cooled to lowest annual rate in two years in April, though the core inflation, which excludes food and ene
CTIC STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of CTI BioPharma Corp. Is Fair to Shareholders
08:46am, Wednesday, 10'th May 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CTI BioPharma Corp. (NASDAQ: CTIC) to Swedish Orphan Biovitrum AB for $9.10 per share is
Why Is CTI BioPharma (CTIC) Stock Up 85% Today?
08:25am, Wednesday, 10'th May 2023
CTI BioPharma (NASDAQ: CTIC ) stock is taking off on Wednesday after the company announced a major acquisition deal with Sobi. This deal has Sobi agreeing to acquire CTI BioPharma for $1.7 billion.
CTI BioPharma Soars After Agreeing $1.7 Billion Sale. Biotech Deals Keep Coming.
07:05am, Wednesday, 10'th May 2023
Swedish Orphan Biovitrum will buy CTI for $9.10 a share as it looks to expand its rare hematology portfolio.
CTI BioPharma soars on deal news, while Upstart and Rivian climb after earnings
05:39am, Wednesday, 10'th May 2023
CTI BioPharma Corp. CTIC stock soared 83% in premarket trading after Swedish Orphan Biovitrum AB SE:SOBI said it had entered into an agreement to acquire the biotech in a deal valued at $1.7 billion.
Swedish Orphan Biovitrum to acquire CTI BioPharma in a deal valued at $1.7 billion
02:26am, Wednesday, 10'th May 2023
Swedish Orphan Biovitrum AB SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. CTIC in a deal valued at $1.7 billion. The Stockholm-based dr
